| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gerard G Hanna | Q43295979 |
| P2093 | author name string | A M Kirby | |
| P2860 | cites work | Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure | Q24542323 |
| The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? | Q26823489 | ||
| Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy | Q28248508 | ||
| Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost | Q28272297 | ||
| Breast boost: are we missing the target? | Q53659756 | ||
| Breast MRI After Conservation Therapy: Usual Findings in Routine Follow-Up Examinations | Q59481236 | ||
| Intraoperative radiotherapy for breast cancer | Q61626894 | ||
| Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery | Q70092232 | ||
| Intraoperative radiation therapy for breast cancer: technical notes | Q73042107 | ||
| Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients | Q74523082 | ||
| Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study | Q75221064 | ||
| Dosimetric characteristics of a low-kV intra-operative x-ray source: implications for use in a clinical trial for treatment of low-risk breast cancer | Q79123252 | ||
| The IMPORT trials are launched (September 2006) | Q79275427 | ||
| Full-Dose Intraoperative Radiotherapy With Electrons During Breast-Conserving Surgery | Q79278953 | ||
| Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy | Q79984869 | ||
| IORT and external beam irradiation (EBI) in clinical stage I-II NSCLC patients with severely compromised pulmonary function: an 52-patient single-institutional experience | Q80426768 | ||
| Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial | Q80495823 | ||
| Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer | Q81294143 | ||
| Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer | Q82371722 | ||
| Mammary fat necrosis following radiotherapy in the conservative management of localized breast cancer: does it matter? | Q83185614 | ||
| Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO) | Q83201086 | ||
| First description of MR mammographic findings in the tumor bed after intraoperative radiotherapy (IORT) of breast cancer | Q84029274 | ||
| Are mammographic changes in the tumor bed more pronounced after intraoperative radiotherapy for breast cancer? Subgroup analysis from a randomized trial (TARGIT-A) | Q85507909 | ||
| Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer | Q87006474 | ||
| Radiotherapy for breast cancer, the TARGIT-A trial | Q95372406 | ||
| Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial | Q28285969 | ||
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 | ||
| Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). | Q33471876 | ||
| The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies | Q33856404 | ||
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials | Q34054354 | ||
| Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. | Q34093366 | ||
| Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy | Q34137724 | ||
| Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery | Q34144051 | ||
| National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. | Q34299708 | ||
| The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre | Q34376320 | ||
| Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial | Q34384718 | ||
| IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin | Q35602161 | ||
| Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience. | Q36198317 | ||
| Radiation protection for an intra-operative X-ray device. | Q36324789 | ||
| Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. | Q36368893 | ||
| Primary extraosseous Ewing sarcoma of the lung in children | Q36791086 | ||
| Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review | Q37265690 | ||
| Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer | Q37532636 | ||
| Breast radiotherapy: less is more? | Q38062756 | ||
| Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria | Q38077708 | ||
| Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer | Q38086491 | ||
| Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer | Q38215041 | ||
| The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction | Q41879769 | ||
| IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis | Q43470885 | ||
| Risk of ischemic heart disease in women after radiotherapy for breast cancer | Q43615460 | ||
| Intraoperative radiation therapy in early breast cancer using a linear accelerator outside of the operative suite: an "image-guided" approach | Q43788018 | ||
| Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma | Q43839751 | ||
| Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer | Q45041163 | ||
| Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer | Q45041166 | ||
| Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible | Q45141808 | ||
| Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy | Q45768619 | ||
| Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. | Q49109112 | ||
| Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. | Q50589582 | ||
| Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. | Q50754518 | ||
| Tumour bed delineation for partial breast/breast boost radiotherapy: what is the optimal number of implanted markers? | Q50796900 | ||
| Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma. | Q51038003 | ||
| Prospective trial of intraoperative radiation treatment for breast cancer. | Q51573534 | ||
| Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. | Q51788799 | ||
| Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. | Q53651005 | ||
| P433 | issue | 1049 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20140686 | |
| P577 | publication date | 2015-03-03 | |
| P1433 | published in | British Journal of Radiology | Q15758529 |
| P1476 | title | Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date | |
| P478 | volume | 88 |
| Q50099153 | Down-regulation of LncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer |
| Q99565356 | Efficacy analysis of intraoperative radiotherapy in patients with early-stage breast cancer |
| Q27013588 | Electronic brachytherapy--current status and future directions |
| Q50142688 | Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report |
| Q37289538 | Novel recombinant protein FlaA N/C increases tumor radiosensitivity via NF-κB signaling in murine breast cancer cells |
Search more.